Sort
8,912 grants matching “sars cov 2”
WCM-Rutgers NJMS CTU Supplement for COVID Testing
$300,000Roy M Gulick · Weill Medical Coll Of Cornell Univ · UM1 · FY2020 · AI
Live Cell Fluorescent Assays for SARS-CoV-2 protease activity and COVID-19 Drug Discovery
$300,000Anne Marie Quinn · Montana Molecular, Llc · R44 · FY2023 · AI
Accelerating Bayesian Dimension Reduction for Dynamic Network Data with Many Observations
$300,000Andrew Holbrook · University Of California-Los Angeles · · FY2022 · MPS
Single Cell RNA Sequencing of Blood and CSF of Patients with NeuroAIDS
$300,000Steven Jacobson · National Institute Of Neurological Disorders And Stroke · ZIA · FY2025 · NS
EAGER: Toward determining the key interactions between the SARS-CoV2 virus components and host cells
$300,000Juliette T Lecomte · Johns Hopkins University · · FY2020 · BIO
SCH: Wearables for Health and Disease Knowledge (W4H)
$300,000Cyrus Shahabi · University Of Southern California · R01 · FY2022 · LM
Gene Gun-delivered RNA vaccines.
$300,000Hannah Frizzell · Orlance, Inc. · R43 · FY2025 · AI
A Novel Multi-Epitope-Based Universal Vaccine Against Multiple Coronavirus Variants of Concern
$300,000Hawa Vahed · Techimmune, Llc · R43 · FY2024 · AI
Treatment of Inflammatory Complications of Viral Pneumonia
$300,000Andy Agrawal · Respana Therapeutics, Inc. · R41 · FY2022 · AI
Live Cell Fluorescent Assays for SARS-CoV-2 protease activity and COVID-19 Drug Discovery
$300,000Anne Marie Quinn · Montana Molecular, Llc · R44 · FY2022 · AI
Single Cell RNA Sequencing of Blood and CSF of Patients with NeuroAIDS
$300,000Steven Jacobson · National Institute Of Neurological Disorders And Stroke · ZIA · FY2024 · NS
IND-Enabling Development of a Small Molecule COVID Therapeutic
$300,000Ryan P Bennett · Oyagen, Inc. · R43 · FY2024 · AI
Innate and Adaptive Immune Responses in SARS-CoV-2 infection (COVID-19)
$300,000Daniel Cesar Douek · National Institute Of Allergy And Infectious Diseases · ZIA · FY2020 · AI
High throughput antibody discovery against cell membrane bound target proteins using innovative MOD technology for direct screening in single-cell assays
$300,000Russell H Cole · Scribe Biosciences, Inc. · R43 · FY2023 · AI
EAGER: Carbon Dot-Based Transformative COVID-19 Therapy
$300,000Roger M Leblanc · University Of Miami · · FY2020 · ENG
Promoting Health, Safety, and Recovery Training for COVID-19 Essential Workers and their Communities
$300,000David Turcotte · University Of Massachusetts Lowell · U45 · FY2022 · ES
New target and new therapy for severe Covid-19 and viral hyperinflammation damage: renalase and renalase agonists
$299,999Barry A Berkowitz · Bessor Pharma, Llc · R43 · FY2023 · AI
EAGER: Investigation of host and viral factors that influence the severity of coronaviral disease
$299,999James D Macy · Yale University · · FY2020 · BIO
PFI-TT: Development of Point-of-Care Biochips for the Rapid and Sensitive Detection of Multiple Respiratory Pathogens
$299,999Xiujun Li · University Of Texas At El Paso · · FY2021 · TIP
EAGER:Immune Response of Jamaican Fruit Bats Experimentally Infected with SARS-CoV-2
$299,998William Schountz · Colorado State University · · FY2020 · BIO
EAGER: RCN: Wastewater Surveillance of SARS-CoV-2
$299,995Kyle Bibby · University Of Notre Dame · · FY2020 · ENG
A Novel, Host-Directed Therapeutic for the Treatment of Sulfur Mustard Induced Lung Injury
$299,993Livia Agnes Veress · Cmtx Biotech, Inc. · R41 · FY2024 · AI
Developing a Thermostable SARS-CoV-2 RBD-particle Vaccine
$299,991Wei-Chiao Huang · Pop Biotechnologies, Inc · R43 · FY2022 · AI
Developing a Thermostable SARS-CoV-2 RBD-particle Vaccine
$299,991Wei-Chiao Huang · Pop Biotechnologies, Inc · R43 · FY2021 · AI
Insights into biomolecular reactivity and structure for virus inactivation prediction
$299,989Yinyin Ye · Suny At Buffalo · · FY2022 · ENG